Tirzepatide to Help People Quit Smoking
Treatments studied
Part of Mental health clinical trials.
This study tests whether tirzepatide, a medication that helps with weight and blood sugar, can also help people quit smoking. You'd receive the medication plus standard quitting support (nicotine patches or gum and a quit-smoking app) over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 65 years old
- Have a BMI of 25 or higher (a measure of body weight relative to height)
- Smoke at least 10 cigarettes daily for the past 6 months, with more than 2 years of smoking history
- Be ready to try quitting within the next 30–60 days
- Able to attend weekly clinic visits for the full study duration
- Willing to use nicotine replacement (patches or gum) and a quit-smoking app alongside the study medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This study tests whether a weekly injection of tirzepatide (a medicine for weight and blood sugar) combined with cognitive-behavioral therapy (counseling) can help people with alcohol use disorder who are also overweight or obese. By reducing alcohol cravings and supporting weight loss, the treatment aims to improve both drinking and health outcomes.
This study tests whether a medication called tirzepatide (originally developed for diabetes) can help people reduce or stop cannabis use. It is for adults who use cannabis frequently and are motivated to seek treatment.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial tests whether a weekly injection called tirzepatide (a diabetes and weight-loss medication) can help people with obesity and stimulant use disorder reduce stimulant use and lose weight. It aims to see if treating both conditions together improves outcomes.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.